首页> 外国专利> Use of the 4- garakutoshiru - xylose in order to appraise the said enzyme with in vivo as a non invasion characteristic diagnostic test of the deficiency of the lactase inside the intestine in the person

Use of the 4- garakutoshiru - xylose in order to appraise the said enzyme with in vivo as a non invasion characteristic diagnostic test of the deficiency of the lactase inside the intestine in the person

机译:为了体内评价上述酶而使用4-garakutoshiru-木糖作为人肠内乳糖酶缺乏症的非侵入性诊断试验

摘要

As for this invention, being the usage in the person of 4- garakutoshiru - xylose, it regards the said use method of including the alternative technology in order to measure the xylose in the urine. This method 4- garakutoshiru - xylose after prescribing to the patient orally, includes the fact that density of the xylose in the blood is measured, the said method is suitable vis-a-vis the newborn baby. This invention regards also the technology which is used in order to appraise the activity of the said enzyme with in vivo with the non invasion test in order to diagnose the deficiency of the intestinal lactase. As for the said technology the fact that all activity of the said enzyme in the individual patient is appraised directly is included, but what appraises the result of the said deficiency is not included. This method does not need, the special device in addition, not only not bringing the clear unpleasant impression, removes the inconvenient point of the diagnostics which is from the past used because reliability quite is high, in the lactase deficiency patient.
机译:关于本发明,作为4-garakutoshiru-木糖在人中的使用,考虑到包括替代技术在内的上述使用方法,以测定尿中的木糖。该方法4-garakutoshiru-木糖口服给患者处方后,包括测量血液中木糖的密度的事实,所述方法相对于新生婴儿是合适的。本发明还涉及用于通过无侵害试验在体内评估所述酶的活性以诊断肠乳糖酶缺乏的技术。对于所述技术,包括直接评估个体患者中所述酶的所有活性的事实,但是不包括评估所述缺陷的结果的事实。该方法不需要,此外,在乳糖酶缺乏症患者中,专用设备不仅不带来清晰的令人不快的印象,而且消除了由于可靠性很高的过去使用的诊断的不便之处。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号